200 related articles for article (PubMed ID: 8117543)
1. Eosinophilia-myalgia syndrome, toxic-oil syndrome, and diffuse fasciitis with eosinophilia.
Silver RM
Curr Opin Rheumatol; 1993 Nov; 5(6):802-8. PubMed ID: 8117543
[TBL] [Abstract][Full Text] [Related]
2. Eosinophilia-myalgia syndrome, toxic-oil syndrome, and diffuse fasciitis with eosinophilia.
Bolster MB; Silver RM
Curr Opin Rheumatol; 1994 Nov; 6(6):642-9. PubMed ID: 7865387
[TBL] [Abstract][Full Text] [Related]
3. Eosinophilia-myalgia syndrome, toxic-oil syndrome, and diffuse fasciitis with eosinophilia.
Silver RM
Curr Opin Rheumatol; 1992 Dec; 4(6):851-6. PubMed ID: 1457280
[TBL] [Abstract][Full Text] [Related]
4. Eosinophilia-myalgia syndrome, toxic-oil syndrome, and diffuse fasciitis with eosinophilia.
Kaufman LD; Krupp LB
Curr Opin Rheumatol; 1995 Nov; 7(6):560-7. PubMed ID: 8579979
[TBL] [Abstract][Full Text] [Related]
5. 3-(Phenylamino)alanine, a novel aniline-derived amino acid associated with the eosinophilia-myalgia syndrome: a link to the toxic oil syndrome?
Mayeno AN; Belongia EA; Lin F; Lundy SK; Gleich GJ
Mayo Clin Proc; 1992 Dec; 67(12):1134-9. PubMed ID: 1469924
[TBL] [Abstract][Full Text] [Related]
6. Eosinophilic rheumatic disorders.
Clauw DJ; Crofford LJ
Rheum Dis Clin North Am; 1995 Feb; 21(1):231-46. PubMed ID: 7732171
[TBL] [Abstract][Full Text] [Related]
7. The eosinophilia-myalgia syndrome and the toxic oil syndrome. Pursuing parallels.
Hertzman PA
Adv Exp Med Biol; 1996; 398():339-42. PubMed ID: 8906286
[No Abstract] [Full Text] [Related]
8. Biotransformation of 3-(phenylamino)-1,2-propanediol to 3-(phenylamino)alanine: a chemical link between toxic oil syndrome and eosinophilia-myalgia syndrome.
Mayeno AN; Benson LM; Naylor S; Colberg-Beers M; Puchalski JT; Gleich GJ
Chem Res Toxicol; 1995; 8(7):911-6. PubMed ID: 8555405
[TBL] [Abstract][Full Text] [Related]
9. [Eosinophilia myalgia syndrome (EMS) caused by L-tryptophan product and toxic oil syndrome (TOS) caused by denatured rape-seed oil].
Maitani T; Saitoh H
Shokuhin Eiseigaku Zasshi; 2009 Dec; 50(6):279-91. PubMed ID: 20065617
[No Abstract] [Full Text] [Related]
10. 3-(Phenylamino)alanine--a link between eosinophilia-myalgia syndrome and toxic oil syndrome?
Philen RM; Hill RH
Mayo Clin Proc; 1993 Feb; 68(2):197-200. PubMed ID: 8423703
[No Abstract] [Full Text] [Related]
11. The toxic oil syndrome and the eosinophilia-myalgia syndrome: pursuing clinical parallels.
Hertzman PA; Borda IA
J Rheumatol; 1993 Oct; 20(10):1707-10. PubMed ID: 8295182
[No Abstract] [Full Text] [Related]
12. Pulmonary hypertension in patients with eosinophilia-myalgia syndrome or toxic oil syndrome.
Cheng TO
Mayo Clin Proc; 1993 Aug; 68(8):823-4. PubMed ID: 8331987
[No Abstract] [Full Text] [Related]
13. AHR activation by tryptophan--pathogenic hallmark of Th17-mediated inflammation in eosinophilic fasciitis, eosinophilia-myalgia-syndrome and toxic oil syndrome?
Rieber N; Belohradsky BH
Immunol Lett; 2010 Feb; 128(2):154-5. PubMed ID: 19941898
[TBL] [Abstract][Full Text] [Related]
14. Toxic oil syndrome: a current clinical and epidemiologic summary, including comparisons with the eosinophilia-myalgia syndrome.
Kilbourne EM; Posada de la Paz M; Abaitua Borda I; Diez Ruiz-Navarro M; Philen RM; Falk H
J Am Coll Cardiol; 1991 Sep; 18(3):711-7. PubMed ID: 1869734
[TBL] [Abstract][Full Text] [Related]
15. [Eosinophilia-myalgia: new syndrome].
Szechiński J; Borysewicz K
Postepy Hig Med Dosw; 1992; 46(3):319-25. PubMed ID: 1369828
[TBL] [Abstract][Full Text] [Related]
16. Cutaneous toxic mucinoses.
Rongioletti F; Rebora A
J Am Acad Dermatol; 1992 May; 26(5 Pt 1):789-90. PubMed ID: 1583189
[No Abstract] [Full Text] [Related]
17. Clinical features of eosinophilia myalgia syndrome and related disorders.
Clauw DJ
Adv Exp Med Biol; 1996; 398():331-8. PubMed ID: 8906285
[TBL] [Abstract][Full Text] [Related]
18. Toxic oil syndrome and eosinophilia-myalgia syndrome: May 8-10, 1991, World Health Organization meeting report.
Philen RM; Posada M
Semin Arthritis Rheum; 1993 Oct; 23(2):104-24. PubMed ID: 8266108
[TBL] [Abstract][Full Text] [Related]
19. Toxic oil syndrome: the perspective after 20 years.
Posada de la Paz M; Philen RM; Borda AI
Epidemiol Rev; 2001; 23(2):231-47. PubMed ID: 12192735
[TBL] [Abstract][Full Text] [Related]
20. Alterations in tryptophan metabolism in the toxic oil syndrome and in the eosinophilia-myalgia syndrome.
Silver RM; Sutherland SE; Carreira P; Heyes MP
J Rheumatol; 1992 Jan; 19(1):69-73. PubMed ID: 1532618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
